Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center ...
Novartis announced fourth quarter and full year financial results for 2020 on January 26, 2021.
Novartis focuses its business on three divisions with innovation power and global scale: pharmaceuticals, eye care and generics.
